Ph.D, MD, MS, MDS or equivalent degree or having 3 years of research, teaching, design and development experience after MVSC, M.Pharm, ME, M.Tech with at least one research paper in Science Citation Index journal. Candidates with equivalent qualification in AYUSH sciences may also apply.
M.Pharm/ME/M.Tech; Lignin valorization via biomaterial development, depolymerization and green technology; project funded by Government of India at Institute of Nano Science and Technology, Mohali. Research experience in Tissue engineering/ Biomaterials / Synthetic Modification of biopolymers/ Proficiency in animal handling is preferable.
M.Sc. Chemistry any discipline, Biotechnology, Microbiology or related field, M. Pharm , M.S. Pharm Biotechnology, Medicinal, Pharmaceutical, Process Chemistry, B.E.,B.Tech.,M.E. , M. Tech. Biotechnology or relevant discipline
Single Crystal growth of hybrid perovskite materials and characterization techniques. Ph.D, MD, MS, MDS or equivalent deegree OR three years of research, teaching, design and development after MVSc,M.Pharm,M.E,M.Tech with at least one research paper in Science Citation Index SCI Journal.
CSIR - North East Institute of Science & Technology, Jorhat, a constituent establishment of CSIR, is a multidisciplinary institute having research areas like Chemical Sciences, Biological Sciences, Materials Sciences, Engineering Sciences, Geological Sciences, Advanced Computation and Data Sciences etc. The institute is equipped with sophisticated state-of-art analytical and other equipment to carry out research activities in frontier areas of science &technology.
M.Pharma, ME,M.Tech with at least one research paper in Science Citation Indexed journal. Understanding pesticides-induced toxicity in gut microbiota; Biomaterial from fungal source for industrial application
Biocon is global biopharmaceutical company changing patients' lives in over 120 countries by finding new and affordable ways to treat diabetes, cancer and autoimmune diseases. Biocon is a research-driven, global healthcare company with a strong matrix of capabilities along the biopharmaceutical value chain.